Dominating Players in the Taiwan Anaphylaxis Market | Competitive Landscape 2026

Dominating Players in the Taiwan Anaphylaxis Market

The Taiwan Anaphylaxis Market is dominated by major pharmaceutical giants, with a large market share, that offers advanced emergency medical treatments and epinephrine delivery systems for severe allergic reactions. The key players in the market are Viatris, Sanofi, and GSK.

Taiwan Anaphylaxis Market Overview

According to 6Wresearch, the Taiwan anaphylaxis market is growing, due to the rising incidences of severe allergic diseases, especially food allergies and hypersensitivity to drug-induced reactions, and increasing public awareness of emergency treatment. Epinephrine is called the first line of treatment, that changes the physiological responses by narrowing the blood vessels and widening the airways in the lungs.

The growth of the market is being driven by the increased use of auto-injector alternatives and hospital-based emergency care. The healthcare infrastructure is becoming more specialized with increasing number of allergy clinics and emergency departments, leading to an expansion in the pharmaceutical supply chain for life saving anti-allergy drugs.

Competitive Landscape

The competitive landscape of the Taiwan Anaphylaxis Industry is characterized by a mix of local distributors and international pharmaceutical giants, offering a range of dosage forms, including epinephrine auto-injectors, pre-filled syringes, and emerging needle-free nasal sprays. The industry leaders are involved in ensuring cost effective treatments and innovative delivery systems are available to build patient adherence.

Below is a list of leading players operating in the Taiwan Anaphylaxis Market:

1. Viatris Taiwan

Viatris is a global leader in the anaphylaxis segment, providing the widely recognized EpiPen, which remains a cornerstone in emergency allergy management in Taiwan.

2. Sanofi Taiwan

Sanofi is a major player in the immunology space, focusing on long-term allergy management and clinical solutions for severe allergic reactions.

3. GSK Taiwan (GlaxoSmithKline)

GSK is a leader in respiratory and allergy health, offering a portfolio of medications that manage the underlying conditions leading to severe allergic episodes.

4. Teva Pharmaceutical Taiwan

Teva provides high-quality generic epinephrine auto-injectors, ensuring that life-saving medications are accessible and affordable.

5. Pfizer Taiwan

Pfizer maintains a strong presence in the emergency medicine segment, providing essential treatments that support the management of systemic allergic reactions.

6. CCPPC (China Chemical & Pharmaceutical Co., Ltd.)

CCPPC is a leading domestic manufacturer, providing essential medications and contributing to the local supply of antihistamines and injectable treatments.

7. Sandoz Taiwan

Sandoz offers a variety of generic treatments and supportive care medications for the management of acute allergic emergencies.

8. Novartis Taiwan

Novartis is a major player in the immunology segment, researching and providing specialty products that support the treatment of severe allergic reactions.

9. Abbott Taiwan

Abbott provides a range of nutritional and pharmaceutical products that assist in managing overall patient health and recovery post-anaphylactic events.

10. TTY Biopharm Company Limited

TTY Biopharm leverages its extensive local production capabilities to provide medications used in the supportive care of allergic emergencies and specialty injectables.

Dominating Players in the Taiwan Anaphylaxis Market: FAQs